Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review

Journal of Infectious Diseases

Volumn 186, Issue , 2002, Pages S3-S28

  Smith, Jennifer S ^a   Robinson, N Jamie ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CONFERENCE PAPER; FEMALE; GEOGRAPHIC DISTRIBUTION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; VIRUS LATENCY;

EID: 0037108418     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/343739     Document Type: Article

References (152)

1. Cusini M, Ghislanzoni M. The importance of diagnosing genital herpes. J Antimicrob Chemother 2001:47(Suppl T1):9-16.
2. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990;69:19-36.
3. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment J Clin Invest 1997:99:1092-7.
4. Corey L, Wald A. Genital herpes. In: Holmes KK, Mardh PA, Sparling PF, et al, eds. Sexually transmitted diseases. New York: McGraw-Hill, 1998; 285-312.
5. Brugha R, Keersmaekers K, Renton A, Meheus A. Genital herpes infection: a review. Int J Epidemiol 1997;26:698-709.
6. Cowan FM, Johnson AM, Ashley RL, Corey L. Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309:1325-9.
7. Smith JS, Herrero R, Muñoz N, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among middle-aged women in Brazil and the Philippines. Sex Transm Dis 2001; 28:187-94.
8. Copas A, Mindel A, Cowan F. Risk scores to improve serological screening for herpes. Int J STD AIDS 2001: 12(Suppl 2):170.
9. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-6.
10. Auvert B, Ballard R, Campbell C, et al. HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS 2001; 15:885-98.
11. Gwanzura L, McFarland W, Alexander D, Burke RL, Katzenstein D. Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe. J Infect Dis 1998; 177:481-4.
12. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002:185:45-52.
13. Weiss HA, Buve N, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations AIDS 2001; 15(Suppl 4):S97-108.
14. Suligoi B, Tchamgmena O, Sarmati L, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among adolescents and adults in northern Cameroon. Sex Transm Dis 2001; 28:690-3.
15. Ghebrekidan H, Ruden U, Cox S, Wahren B, Grandien M. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol 1999; 12:53-64.
16. Walraven G, Scherf C, West B, et al. The burden of reproductive-organ disease in rural women in The Gambia, West Africa. Lancet 2001;357: 1161-7.
17. Shaw M, van der Sande M, West B, et al. Prevalence of herpes simplex type 2 and syphilis serology among young adults in a rural Gambian community. Sex Transm Infect 2001; 77:358-65.
18. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999; 179:16-24.
19. Kamali A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG, Whitworth JA. Seroprevalence and incidence of genital ulcer infections in a rural Ugandan population. Sex Transm Infect 1999; 75:98-102.
20. Wagner HU, Van Dyck E, Roggen E, et al. Seroprevalence and incidence of sexually transmitted diseases in a rural Ugandan population. Int J STD AIDS 1994; 5:332-7.
21. Wawer MJ, Eng SM, Serwadda D, et al. Prevalence of Kaposi sarcoma-associated herpesvirus compared with selected sexually transmitted diseases in adolescents and young adults in rural Rakai District, Uganda. Sex Transm Dis 2001;28:77-81.
22. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999;180:1459-65.
23. Gregson S, Mason PR, Garnett GP, et al. A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS 2001; 12:189-96.
24. Hildesheim A, Mann V, Brinton LA. Szklo M, Reeves WC, Rawls WE. Herpes simplex virus type 2: a possible interaction with human papillomavirus types 16/18 in the development of invasive cervical cancer. Int J Cancer 1991;49:335-40.
25. Carvalho M, de Carvalho S, Punnuti CS, Sumita LM, de Souza VA. Prevalence of herpes simplex type 2 antibodies and a clinical history of herpes in three different populations in Campinas City, Brazil. Int J Infect Dis 1998-9;3:94-8.
26. Weinberg A, Canto CL, Pannuti CS, Kwang WN, Garcia SA, Zugaib M. Herpes simplex virus type 2 infection in pregnancy: asymptomatic viral excretion at delivery and seroepidemiologic survey of two socioeconomically distinct populations in Saõ Paulo, Brazil. Rev Inst Med Trop Saõ Paulo 1993;35:285-90.
27. de San José S. Munõz N, Bosch FX, et al. Sexually transmitted agents and cervical neoplasia in Colombia and Spain. Int J Cancer 1994;56:358-63.
28. Stone KM, Zaidi A, Rosero BL, et al. Sexual behavior, sexually transmitted diseases, and risk of cervical cancer. Epidemiology 1995;6:409-14.
29. Oberle MW, Rosero-Bixby L, Lee FK, Sanchez-Braverman M, Nahmias AJ, Guinan ME. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg 1989;41: 224-9.
30. Boulos R, Ruff AJ, Nahmias A, et al. Herpes simplex virus type 2 infection, syphilis, and hepatitis B virus infection in Haitian women with human immunodeficiency virus type 1 and human T lymphotropic virus type 1 infections. J Infect Dis 1992; 166:418-20.
31. Lazcano-Ponce E, Smith J, Muñoz N, et al. High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico City, Mexico. A population based-study. Sex Transm Dis 2001;28:270-6.
32. Hernández-Girón C, Uribe-Salas F, Conde-Gonzalez C, et al. Seroprevalence of various viruses and sociodemographic characteristics of women seeking HIV screening Rev Invest Clin 1997;49:5-13.
33. Sánchez J, Gotuzzo E, Escamilla J, et al. Gender differences in sexual practices and sexually transmitted infections among adults in Lima, Peru. Am J Public Health 1996;86:1098-107.
34. Patrick DM, Dawar M, Cook DA, Krajden M, Ng HC, Rekart ML. Antenatal seroprevalence of herpes simplex virus type 2 (HSV-2) in Canadian women: HSV-2 prevalence increases throughout the reproductive years. Sex Transm Dis 2001:28:424-8.
35. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-11.
36. Xu F, Schillinger JA, Sternberg MR, et al. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J Infect Dis 2002; 185:1019-24.
37. Frenkel LM, Garratty EM, Shen JP, Wheeler N, Clark O, Bryson YJ. Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 1993; 118:414-8.
38. Graham S, Rawls W, Swanson M, McCurtis J. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix. Am J Epidemiol 1982; 115:729-35.
39. Ruiz JD, Molitor F, McFarland W, et al. Prevalence of HIV infection, sexually transmitted diseases, and hepatitis and related risk behavior in young women living in low-income neighborhoods of northern California. West J Med 2000; 172:368-73.
40. Buchacz K, McFarland W, Hernandez M, et al. Prevalence and correlates of herpes simplex virus type 2 infection in a population-based survey of young women in low-income neighborhoods of northern California. Sex Transm Dis 2000;27:393-400.
41. Siegel D, Golden E, Washington AE, et al. Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study. JAMA 1992;268:1702-8.
42. Boucher FD, Yasukawa LL, Bronzan RN, Hensleigh PA, Arvin AM, Prober CG. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr Infect Dis J 1990; 9:499-504.
43. Bunnell RE, Dahlberg L, Rolfs R, et al. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis 1999; 180:1624-31.
44. Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted disease and other risk factors for cervical dysplasia among southwestern Hispanic and non-Hispanic white women. JAMA 1994; 271:1181-8.
45. Becker TM, Lee F, Daling JR, Nahmias AJ. Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women. Sex Transm Dis 1996; 23:138-44.
46. Becker TM, Magder L, Harrison HR, et al. The epidemiology of infection with the human herpesviruses in Navajo children. Am J Epidemiol 1988; 127:1071-8.
47. Friedman SR, Curtis R, Jose B, et al. Sex, drugs, and infections among youth. Parenterally and sexually transmitted diseases in a high-risk neighborhood. Sex Transm Dis 1997; 24:322-6.
48. Lewis LM, Bernstein DI, Rosenthal SL, Stanberry LR. Seroprevalence of herpes simplex virus-type 2 in African-American college women. J Natl Med Assoc 1999;91:210-2.
49. Noell J, Rohde P, Octis L, et al. Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis 2001;28:4-10.
50. Cook RL, Pollock NK, Rao AK, Clark DB. Increased prevalence of herpes simplex virus type 2 among adolescent women with alcohol use disorders. J Adolesc Health 2002; 30:169-74.
51. Breinig MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162:299-305.
52. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis 1990; 162:306-12.
53. Adler-Storthz K, Dreesman GR, Kaufman RH, Melnick JL, Adam E. A prospective study of herpes simplex virus infection in a defined population in Houston, Texas. Am J Obstet Gynecol 1985; 151:582-6.
54. Sucato G, Celum C, Dithmer D, Ashley R, Wald A. Demographic rather than behavioral risk factors predict herpes simplex virus type 2 infection in sexually active adolescents. Pediatr Infect Dis J 2001;20:422-6.
55. Hitti J, Watts H, Burchett SK, et al. Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. Am J Obstet Gynecol 1997; 177:450-4.
56. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997;24:149-55.
57. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997;337:509-15.
58. Oliver L, Wald A, Kim M, et al. Seroprevalence of herpes simplex virus infections in a family medicine clinic. Arch Fam Med 1995;4:228-32.
59. Koutsky LA, Ashley RL, Holmes KK, et al. The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 1990; 17:90-4.
60. Maden C. Beckmann AM, Thomas DB, et al. Human papillomaviruses, herpes simplex viruses, and the risk of oral cancer in men. Am J Epidemiol 1992; 135:1093-102.
61. Tideman RL, Taylor J, Marks C, et al. Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sex Transm Infect 2001; 77:413-5.
62. Mindel A, Taylor J, Tideman RL, et al. Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect 2000; 76:287-91.
63. Cunningham AL, Lee FK, Ho DW, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993; 158:525-8.
64. Bogaerts J, Ahmed J, Akhter N, et al. Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection. Sex Transm Infect 2001; 77:114-9.
65. Peng HQ, Liu SL, Mann V, Rohan T, Rawls W. Human papillomavirus types 16 and 33, herpes simplex virus type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer 1991;47:711-6.
66. Lo JY, Lim WW, Ho DW, Field PR, Cunningham AL. Difference in seroprevalence of herpes simplex virus type 2 infection among antenatal women in Hong Kong and southern China. Sex Transm Infect 1999; 75: 123.
67. Hashido M, Kawana T, Matsunaga Y, Inouye S. Changes in prevalence of herpes simplex virus type 1 and 2 antibodies from 1973 to 1993 in the rural districts of Japan. Microbiol Immunol 1999;43:177-80.
68. Hashido M, Lee FK, Nahmias AJ, et al. An epidemiologic study of herpes simplex virus type 1 and 2 infection in Japan based on type-specific serological assays. Epidemiol Infect 1998; 120:179-86.
69. Eberhart-Phillips JE, Dickson NP, Paul C, Herbison GP, Taylor J, Cunningham AL. Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders. Sex Transm Infect 2001; 77:353-7.
70. Eberhart-Phillips J, Dickson NP, Paul C, et al. Herpes simplex type 2 infection in a cohort aged 21 years. Sex Transm Infect 1998; 74:216-8.
71. Dobbins JG, Mastro TD, Nopkesorn T, et al. Herpes in the time of AIDS: a comparison of the epidemiology of HIV-1 and HSV-2 in young men in northern Thailand. Sex Transm Dis 1999;26:67-74.
72. Nelson KE, Eiumtrakul S, Celentano D, et al. The association of herpes simplex virus type 2 (HSV-2), Haemophilus ducreyi, and syphilis with HIV infection in young men in northern Thailand. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16:293-300.
73. Kjaer SK, de-Villiers EM, Haugaard BJ, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 1988;41: 518-24.
74. Arvaja M, Lehtinen M, Koskela P. Lappalainen M, Paavonen J, Vesikari T. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect 1999; 75:168-71.
75. Lehtinen M, Dillner J, Knekt P, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996; 312:537-9.
76. Hakama M, Lehtinen M, Knekt P, et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol 1993; 137:166-70.
77. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations-relevance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
78. Rabenau HF, Buxbaum S, Preiser W, Weber B, Doerr HW. Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (Berl) 2002; 190:153-60.
79. Bahrdt B, Rabenau H, Weber B, Eibner J, Doerr HW. Prevalence of herpes-simplex-virus type 2 specific antibodies in patients with different risks of infection. Z Hautkr 1991;67:56-8.
80. Enders G, Risse B, Zauke M, Bolley I, Knotek F. Seroprevalence study of herpes simplex virus type 2 among pregnant women in Germany using a type-specific enzyme immunoassay. Eur J Clin Microbiol Infect Dis 1998; 17:870-2.
81. Isacsohn M, Smetana Z, Rones ZZ, et al. A sero-epidemiological study of herpes virus type 1 and 2 infection in Israel. J Clin Virol 2002; 24:85-92.
82. Pasquini P, Mele A, Franco E, Ippolito G, Svennerholm B. Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy [letter]. Eur J Clin Microbiol Infect Dis 1988; 7:54-6.
83. Franco E, Caprilli F, Zaratti L, Pasquini P. Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy [letter]. Eur J Clin Microbiol 1987;6:322.
84. Sagnelli E, Filippini P, Guarino M, et al. Epidemiological evaluations of human immunodeficiency virus, herpes simplex virus type 1 and 2 and cytomegalovirus infections in drug addicts. Ann Ital Med Int 1989;4: 98-104.
85. Abuharfeil N, Meqdam MM. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan. New Microbiol 2000;23:235-9.
86. Eskild A, Jeansson S, Jenum PA. Antibodies against herpes simplex-virus type 2 among pregnant women in Norway [in Norwegian]. Tidsskr Nor Laegeforen 1999; 119:2323-6.
87. Olsen AO, Orstavik I, Dillner J, Vestergaard BF, Magnus P. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS 1998; 106: 417-24.
88. Garcia-Corbeira P, Dal Re R, Aguilar L, Granizo JJ, Garcia-de-Lomas J. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol 1999; 59:194-7.
89. de Ory F, Pachon I, Echevarria JM, Ramirez R. Seroepidemiological study of herpes simplex virus in the female population in the autonomous region of Madrid, Spain. Eur J Clin Microbiol Infect Dis 1999;18: 678-80.
90. Gil A, Gonzalez A, Dal Re R, Ortega P, Dominguez V. Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents. J Infect 1998; 36:53-6.
91. Andersson-Ellström A, Svennerholm B, Forssman L. Prevalence of antibodies to herpes simplex virus types 1 and 2, Epstein-Barr virus and cytomegalovirus in teenage girls. Scand J Infect Dis 1995;27:315-8.
92. Persson K, Mansson A, Jonsson E, Nordenfelt E. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995; 27:195-9.
93. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-6.
94. Christenson B, Bottiger M, Svensson A, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus types 1 and 2 in a cohort of young girls. J Infect 1992;25:147-54.
95. Laubereau B, Zwahlen M, Neuenschwander B, Heininger U, Schaad UB, Desgrandchamps D. Herpes simplex virus type 1 and 2 in Switzerland. Schweiz Med Wochenschr 2000; 130:143-50.
96. Ibrahim AI, Kouwatli KM, Obeid MT. Frequency of herpes simplex virus in Syria based on type-specific serological assay. Saudi Med J 2000;21: 355-60.
97. Arseven G, Tuncel E, Tuncel S, Sonmez E, Gulen AK. Distribution of HSV-1 and HSV-2 antibodies in pregnant women [in Turkish]. Mikrobiyol Bul 1992;26:359-66.
98. Vyse AJ, Gay NJ, Slomka MJ, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76:183-7.
99. Jha PK, Beral V, Peto J, et al. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 1993; 341:1116-8.
100. Herbert AM, Bagg J, Walker DM, Davies KJ, Westmoreland D. Seroepidemiology of herpes virus infections among dental personnel. J Dent 1995; 23:339-42.
101. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989;43: 53-60.
102. Nzila N, Laga M, Thiam MA, et al. HIV and other sexually transmitted diseases among female prostitutes in Kinshasa. AIDS 1991;5:715-21.
103. Rakwar J, Lavreys L, Thompson ML, et al. Cofactors for the acquisition of HIV-1 among heterosexual men: prospective cohort study of trucking company workers in Kenya. AIDS 1999; 13:607-14.
104. Dada AJ, Ajayi AO, Diamondstone L, Quinn TC, Blattner WA, Biggar RJ. A serosurvey of Haemophilus ducreyi, syphilis, and herpes simplex virus type 2 and their association with human immunodeficiency virus among female sex workers in Lagos. Nigeria. Sex Transm Dis 1998;25:237-42.
105. Dada AJ, Oyewole F, Onofowokan R, et al. Demographic characteristics of retroviral infections (HIV-1, HIV-2, and HTLV-1) among female professional sex workers in Lagos, Nigeria. J Acquir Immune Defic Syndr 1993;6:1358-63.
106. Chen CY, Ballard RC, Beck-Sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000;27:21-9.
107. Langeland N, Haarr L, Mhalu F. Prevalence of HSV-2 antibodies among STD clinic patients in Tanzania. Int J STD AIDS 1998;9:104-7.
108. Conde-Glez CJ, Juarez-Figueroa L, Uribe-Salas F, et al. Analysis of herpes simplex virus 1 and 2 infection in women with high risk sexual behavior in Mexico. Int J Epidemiol 1999;28:571-6.
109. Uribe-Salas F, Hernandez-Avila M, Juarez-Figueroa L, Conde-Glez CJ, Uribe-Zuniga P. Risk factors for herpes simplex virus type 2 infection among female commercial sex workers in Mexico City. Int J STD AIDS 1999; 10:105-11.
110. Uribe-Salas F, Hernandez-Giron C, Conde-Gonzalez C, Cruz-Valdez A, Juarez-Figueroa L, Hernandez-Avila M. Characteristics related to STD/ HIV in men working in Mexico City bars where female prostitution takes place. Salud Publica Mex 1995;37:385-93.
111. Irwin KL, Edlin BR, Wong L, et al. Urban rape survivors: characteristics and prevalence of human immunodeficiency virus and other sexually transmitted infections. Obstet Gynecol 1995; 85:330-6
112. Austin H, Macaluso M, Nahmias A, et al. Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic. Sex Transm Dis 1999; 26:329-34.
113. Huerta K. Berkelhamer S. Klein J, Ammerman S, Chang J, Prober CG. Epidemiology of herpes simplex virus type 2 infections in a high-risk adolescent population. J Adolesc Health 1996; 18:384-6.
114. Rosenthal SL. Stanberry LR, Biro FM, et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin Infect Dis 1997;24:135-9.
115. Kingsley LA, Armstrong J. Rahman A, Ho M, Rinaldo CR Jr. No association between herpes simplex virus type-2 seropositivity or anogenital lesions and HIV seroconversion among homosexual men. J Acquir Immune Defic Syndr 1990;3:773-9.
116. Whittington WL, Celum CL, Cent A, Ashley RL. Use of a glycoprotein G-based type-specific assay to detect antibodies to herpes simplex virus type 2 among persons attending sexually transmitted disease clinics. Sex Transm Dis 2001;28:99-104.
117. Tabet SR, Krone MR, Paradise MA, Corey L, Stamm WE, Celum CL. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS 1998; 12: 2041-8.
118. Schwebke J, Calsyn D, Shriver K, et al. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. J Infect Dis 1994; 169:962-7.
119. Koutsky LA, Holmes KK. Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-8.
120. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-33.
121. Russell DB, Tabrizi SN, Russell JM, Garland SM. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol 2001:22:305-13.
122. Butler T, Donovan B, Taylor J, et al. Herpes simplex virus type 2 in prisoners, New South Wales, Australia, Int J STD AIDS 2000; 11:743-7.
123. Bassett I, Donovan B, Bodsworth NJ, et al. Herpes simplex virus type 2 infection of heterosexual men attending a sexual health centre. Med J Aust 1994; 160:697-700.
124. Rahman M, Alam A, Nessa K, et al. Etiology of sexually transmitted infections among street-based female sex workers in Dhaka, Bangladesh. J Clin Microbiol 2000; 38:1244-6.
125. Perkins NL, Coughlan EP, Franklin RA, Reid MR, Taylor J. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients. N Z Med J 1996; 109:402-5.
126. Limpakarnjanarat K, Mastro TD, Saisorn S, et al. HIV-1 and other sexually transmitted infections in a cohort of female sex workers in Chiang Rai, Thailand. Sex Transm Infect 1999; 75:30-5.
127. Janier M, Lassau F, Bloch J, et al. Seroprevalence of herpes simplex virus type 2 antibodies in an STD clinic in Paris. Int J STD AIDS 1999; 10: 522-6.
128. Cusini M, Cusan M, Parolin C, et al. Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy. Sex Transm Dis 2000;27:292-5.
129. Mele A, Franco E, Caprilli F, et al. Genital herpes infection in outpatients attending a sexually transmitted disease clinic in Italy. Eur J Epidemiol 1988;4:386-8.
130. Dukers NH, Bruisten SM, van den Hoek JA, de Wit JB, van Doornum GJ, Coutinho RA. Strong decline in herpes simplex virus antibodies over time among young homosexual men is associated with changing sexual behavior. Am J Epidemiol 2000; 152:666-73.
131. van de Laar MJ, Termorshuizen F, Slomka MJ, et al. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioral risk factors. Int J Epidemiol 1998;27:127-34.
132. Keet IP, Lee FK, van Griensven GJ, Lange JM, Nahmias A, Coutinho RA. Herpes simplex virus type 2 and other genital ulcerative infections as a risk factor for HIV-1 acquisition. Genitourin Med 1990;66:330-3.
133. Roest R, van Der Meijden W, van Dijk G, et al. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic. Int J Epidemiol 2001;30: 580-8.
134. Varela JA, Garcia-Corbeira P, Aguanell MV, et al. Herpes simplex virus type 2 seroepidemiology in Spain: prevalence and seroconversion rate among sexually transmitted disease clinic attendees. Sex Transm Dis 2001;28: 47-50.
135. Löwhagen GB, Jansen E, Nordenfelt E, Lycke E. Epidemiology of genital herpes infections in Sweden. Acta Derm Venereol 1990;70:330-4.
136. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989;321:7-12.
137. Kjaer SK, de Villiers EM, Caglayan H, et al. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)-a second look. Br J Cancer 1993;67:830-7.
138. Mihret W, Rinke de Wit TF, Petros B, et al. Herpes simplex virus type 2 seropositivity among urban adults in Africa: results from two crosssectional surveys in Addis Ababa. Ethiopia. Sex Transm Dis 2002;29: 175-81.
139. Halioua B. Malkin JE. Epidemiology of genital herpes-recent advances. Eur J Dermatol 1999;9:177-84.
140. Smith JS, Herrero R, Muñoz N, et al. Population-based herpes simplex virus seroprevalence in seven countries. Int J STD AIDS 2001; 12(Suppl 2):62.
141. Pebody RG, Gopal R, Brown D, Miller L, the European HSV Seroepidemiology Multi-Centre Study Group. Multi-centre HSV-1 and HSV-2 seroprevalence study. Int J STD AIDS 2001;12(Suppl 2):148.
142. Howard M, Sellors J, Jang D, et al. Canadian serosurvey of herpes simplex virus (HSV) in Ontario residents. Int J STD AIDS 2001; 12(Suppl 2): 149.
143. French RS, Mayaud P, Brown DWG, HSV Seroepidemiology International Multi-Centre Study Group. International multi-centre HSV-1 and HSV-2 seroprevalence study. Int J STD AIDS 2001; 12(Suppl 2): 148.
144. Malkin JE, Malvy D, Morand P, et al. Seroprevalence of HSV-1 and HSV-2 infections in the French general population [abstract 1315]. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1999:424.
145. Smith JS, Bosetti C, Herrero R, et al. Herpes simplex virus seroprevalence and associated HSV-2 risk factors among cytologically normal, middle-aged women from six countries. Int J STD AIDS 2001; 12(Suppl 2):149.
146. Stanberry LR. Control of STDs-the role of prophylactic vaccines against herpes simplex virus. Sex Transm Infect 1998;74:391-4.
147. Krause PR, Straus SE. Herpesvirus vaccines. Development, controversies, and applications. Infect Dis Clin North Am 1999;13:61-81.
148. Elias C, Heise L. Development of microbicides: a new method of HIV prevention for women. The Population Council. Working Papers no. 6, 1993.
149. Slomka MJ. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun Dis Rep CDR Rev 1996;6:R41-5.
150. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75: 3-17.
151. Severson JL, Tyring SK. Relation between herpes simplex viruses and human immunodeficiency virus infections. Arch Dermatol 1999;135: 1393-7.
152. Cowan F, Langhaug L, Swarthout T, et al. Interaction of HSV-2 and HIV in rural Zimbabwean sex workers (SW) [poster]. Presented at the International Congress on Sexually Transmitted Infections. Berlin, 2001.